Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
about
Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomasLinking functional decline of telomeres, mitochondria and stem cells during ageingTelomere dysfunction suppresses multiple endocrine neoplasia in mice.Regulation of senescence in cancer and aging.E4F1 deficiency results in oxidative stress-mediated cell death of leukemic cellsP66SHC deletion improves fertility and progeric phenotype of late-generation TERC-deficient mice but not their short lifespan.Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenesTelomere dynamics in mice and humansTelomere dysfunction and tumour suppression: the senescence connectionp16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.Extracting extra-telomeric phenotypes from telomerase mouse models.Telomeres and telomerase in cancerThe role of telomere shortening in somatic stem cells and tissue aging: lessons from telomerase model systems.Gankyrin promotes the proliferation of gastric cancer and is associated with chemosensitivity.Telomere-driven diseases and telomere-targeting therapies.Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.Expression of p16 protein in infantile hemangioma.Telomere stability and carcinogenesis: an off-again, on-again relationship.Ink4-Arf locus in cancer and aging.Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.Dysfunctional telomeres and hematological disorders.Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging.
P2860
Q24310863-EEF917AF-5007-4671-A1A0-765824AF0FFAQ28277689-4EBDECC4-4293-4AA3-8D8B-115800C2317DQ34405462-9A095533-5030-49D9-8442-1DDC2D9A2728Q34665706-32D1844E-DD2A-473F-A11D-4062FA00A656Q35102302-5F566CC1-2ED1-4258-8A15-59640D04E5D3Q36863716-93B561CC-EBB3-4D41-A250-9E4EE0DDC678Q37001693-EA9BD359-4669-4E42-A786-D729AF67DBCDQ37091301-AB0BFF9E-71AD-4E8D-8E73-5F59A3B1B34CQ37171810-FCF9A663-7E8F-4228-A8B1-64CFCFA94665Q37200881-6EC6DE4C-95EA-4FE1-ACCA-5DF38002AD77Q37418806-AFA89DCF-14DA-4D85-A862-4C07DCFFC5EBQ37627017-8DBCD379-76A7-4A32-A9E5-4435DE56B11FQ38035437-AD8EF5BA-5AE4-44EB-957B-E29293E9D689Q38698888-BC1C4A31-5967-4B90-8D73-CA3158ECAD04Q39158816-59E0E100-C696-4CD4-BBDC-1D9933F49C6CQ39176621-4420D6AC-9550-4A1A-A5C5-3B2E47577159Q41949825-5551C492-E76A-4EC1-B25C-9DBF09E04C07Q42136961-629F4544-B921-4A66-B195-69729E83A50CQ42153635-815C5286-AADC-47B6-8EE2-60583B46B56CQ42945764-4C48A1C2-3009-452E-8527-D06B57F281B7Q45263078-149701D2-FECF-459D-B9C7-A4257284317FQ50054621-7B73925E-27F7-4B2D-9020-4B1E0D35BBE7Q51864239-9DED5436-8D63-4A2A-A977-6B523EDAA448
P2860
Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Ink4a/Arf tumor suppressor doe ...... he telomerase-deficient mouse.
@ast
Ink4a/Arf tumor suppressor doe ...... he telomerase-deficient mouse.
@en
type
label
Ink4a/Arf tumor suppressor doe ...... he telomerase-deficient mouse.
@ast
Ink4a/Arf tumor suppressor doe ...... he telomerase-deficient mouse.
@en
prefLabel
Ink4a/Arf tumor suppressor doe ...... he telomerase-deficient mouse.
@ast
Ink4a/Arf tumor suppressor doe ...... he telomerase-deficient mouse.
@en
P2093
P2860
P356
P1476
Ink4a/Arf tumor suppressor doe ...... he telomerase-deficient mouse.
@en
P2093
Christine M Khoo
Daniel R Carrasco
Ji-Hye Paik
Marcus W Bosenberg
Ronald A Depinho
P2860
P304
P356
10.1073/PNAS.0700093104
P407
P577
2007-02-27T00:00:00Z